pantoprazole + levofloxacin + azithromycin

Pantoprazole + levofloxacin + azithromycin is a combination of three pharmaceutical agents, each with distinct mechanisms of action. Pantoprazole is a proton pump inhibitor that suppresses gastric acid secretion by irreversibly inhibiting the (H+, K+)-ATPase enzyme in gastric parietal cells, leading to reduced stomach acidity[7]. Levofloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication and cell division, resulting in bactericidal activity[2][8]. Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, blocking peptide chain elongation and thus preventing bacterial growth[6]. This combination may be used off-label for certain infections or as part of regimens targeting resistant or mixed infections; however, it is not an established fixed-dose combination product.